These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 35194719)

  • 1. Direct Granule Feeding of Thermal Droplet Deposition 3D Printing of Porous Pharmaceutical Solid Dosage Forms Free of Plasticisers.
    McDonagh T; Belton P; Qi S
    Pharm Res; 2022 Mar; 39(3):599-610. PubMed ID: 35194719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing.
    Zhang B; Nasereddin J; McDonagh T; von Zeppelin D; Gleadall A; Alqahtani F; Bibb R; Belton P; Qi S
    Int J Pharm; 2021 Jul; 604():120626. PubMed ID: 33957266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the effects of geometric scaling and pore structure on drug dose and release of 3D printed solid dosage forms.
    McDonagh T; Belton P; Qi S
    Eur J Pharm Biopharm; 2022 Aug; 177():113-125. PubMed ID: 35779743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulating drug release from 3D printed dual-drug loaded polypills using challenging polymer compositions.
    McDonagh T; Belton P; Qi S
    Int J Pharm; 2023 Apr; 637():122895. PubMed ID: 36972779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms.
    Krueger L; Miles JA; Popat A
    J Control Release; 2022 Nov; 351():444-455. PubMed ID: 36184971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
    Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
    Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C
    Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
    Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
    Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
    Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation and
    Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.
    Funk NL; Fantaus S; Beck RCR
    Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties.
    Thakkar R; Zhang Y; Zhang J; Maniruzzaman M
    Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and advanced characterization of highly drug-loaded, 3D printed orodispersible tablets containing fluconazole.
    Pyteraf J; Jamróz W; Kurek M; Bąk U; Loskot J; Kramarczyk D; Paluch M; Jachowicz R
    Int J Pharm; 2023 Jan; 630():122444. PubMed ID: 36503848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.